The global one step RT-qPCR kits market is projected to grow steadily, reaching a market value of USD 111.1 million in 2024, with a projected CAGR of 4.9% over the next decade. By 2034, the market is expected to surpass USD 180 million.

A Full Report Overview :
https://www.globenewswire.com/en/news-release/2024/09/25/2953175/0/en/The-One-Step-RT-qPCR-Kits-Market-is-Poised-for-Significant-Expansion-projected-to-Reach-USD-180-0-Million-by-2034-With-a-4-9-CAGR-Driven-by-Advancements-in-Molecular-Diagnostics.html

Understanding the Bulk-Drug Compounding Market:

The One Step RT-qPCR Kits Market is expected to experience steady growth over the next decade, driven by increasing demand for rapid and precise diagnostics in molecular biology. With applications spanning across clinical diagnostics, research, and biotechnology, these kits are vital tools in the detection of viral, bacterial, and genetic material in real-time.

By 2024, the market size is anticipated to reach USD 111.1 million, with a forecast to grow to USD 180.0 million by 2034. This growth reflects a compound annual growth rate (CAGR) of 4.9% during the forecast period. The rising prevalence of infectious diseases, coupled with the need for effective and timely diagnostic solutions, is a primary factor fuelling market demand.

Recent technological advancements in RT-qPCR kits, including enhanced sensitivity, specificity, and faster turnaround times, are boosting their adoption in research institutions and healthcare settings alike. Governments' investments in healthcare infrastructure and pandemic preparedness are also contributing to market growth, ensuring the availability of high-quality diagnostic tools globally.

Furthermore, growing interest in personalized medicine and genomics is expected to create new opportunities for the One Step RT-qPCR Kits Market, particularly in the fields of cancer research, genetic disorder screening, and pharmaceutical development.
 
Drivers and Opportunities

The increasing need for accurate diagnostic solutions in the wake of emerging infectious diseases, such as COVID-19, is driving the demand for One Step RT-qPCR kits. These kits enable rapid detection and quantification of nucleic acids, making them indispensable in identifying pathogens and monitoring disease progression.

Moreover, the growing focus on point-of-care diagnostics, which require highly sensitive yet user-friendly tools, is pushing manufacturers to innovate. The integration of advanced technologies like automation, improved reagents, and simplified protocols is anticipated to drive market expansion.

Additionally, the rise of government and private sector funding in biotechnology research, coupled with the growing emphasis on personalized healthcare, presents lucrative opportunities for market players to expand their product offerings and market reach.

Key Takeaways from Market Study

The One Step RT-qPCR Kits Market is expected to grow from USD 111.1 million in 2024 to USD 180.0 million in 2034, at a CAGR of 4.9%.
Increasing prevalence of infectious diseases and advancements in diagnostic technologies are key drivers for market growth.
Technological innovations such as automation and enhanced reagent performance are contributing to the wider adoption of these kits in clinical and research settings.
North America is projected to remain the largest regional market, while Asia-Pacific is expected to witness the fastest growth due to rising investments in healthcare infrastructure.

Component Insights

One Step RT-qPCR kits consist of several key components, including reverse transcriptase, polymerase enzymes, buffers, and dNTPs, which are essential for the efficient conversion of RNA into cDNA and its subsequent amplification. Manufacturers are continuously optimizing these components to improve performance, reduce error rates, and enable faster results.

High-performance kits are increasingly being adopted by laboratories and research centres due to their ability to provide real-time data in minimal time, making them a preferred choice for critical diagnostics and research.

Market's Prime Determinants of Growth, Trends, and Opportunities

The One Step RT-qPCR Kits Market is being propelled by several key factors:

Infectious Disease Detection: The surge in infectious diseases such as COVID-19, flu, and emerging pathogens has heightened the need for rapid, accurate testing, leading to greater use of RT-qPCR kits.
Technological Advancements: Continuous innovations in enzyme formulations, automation, and multiplexing capabilities are making RT-qPCR kits more efficient and accessible.
Government and Private Sector Investments: Significant financial backing from governments and private sectors in healthcare infrastructure and biotechnology research is boosting the market.
Growing Focus on Personalized Medicine: Increasing interest in personalized medicine is driving demand for molecular diagnostics, where RT-qPCR kits play a crucial role.
Growth Drivers

The following factors are driving the growth of the One Step RT-qPCR Kits Market:

Rapid Rise in Infectious Diseases: The ongoing need to combat viral outbreaks and other infectious diseases is driving demand for faster and more accurate diagnostic tools.
Expansion of Research and Development Activities: Increasing R&D investments in biotechnology, genomics, and personalized medicine are creating new opportunities for RT-qPCR kit manufacturers.
Technological Innovations: Ongoing advancements in real-time PCR technologies are improving the sensitivity, specificity, and speed of these kits, making them indispensable in clinical diagnostics and research.

Competitive Landscape of the One Step RT-qPCR Kits Industry

The one step RT-qPCR kits market is experiencing a wave of consolidation as well-established players acquire smaller companies to capitalize on their technological innovations. This strategy is allowing larger companies to diversify their product portfolios, giving them a competitive edge in the market. The COVID-19 pandemic further intensified the demand for rapid diagnostic solutions, prompting many companies to introduce new diagnostic kits to meet market needs and seize growth opportunities.

One of the key strategies adopted by industry leaders is securing product approvals across multiple countries. This approach helps companies increase their revenue streams by tapping into new markets and expanding their global presence.

Recent Industry Developments in the One Step RT-qPCR Kits Market:

In July 2023, Fortis Life Sciences, LLC acquired International Point of Care, Inc. (IPOC), a Toronto-based company known for producing diagnostic components like lyophilized reagents and recombinant proteins, expanding Fortis’s diagnostic capabilities.
In August 2021, QIAGEN N.V. reached a significant milestone by processing over three billion biological samples using its consumable kits. This achievement underscores the company’s leading role in providing essential molecular laboratory tools for research, disease management, and forensics, further solidifying its position in the global diagnostics market.
In July 2021, Fortis Life Sciences also acquired nanoComposix, a specialist in nanomaterials for assay development and diagnostics. The acquisition bolstered Fortis’s capabilities in nanotechnology, strengthening its position in drug delivery and imaging applications.
In October 2020, New England Biolabs (NEB) launched the Luna Probe One-Step RT-qPCR 4X Mix with UDG, adding to the company’s product line aimed at improving the accuracy and efficiency of diagnostic testing.
Key Players of the One Step RT-qPCR Kits Industry:

Thermo Fisher Scientific Inc.
QIAGEN
Takara Bio Inc.
Bio-Rad Laboratories, Inc.
Promega Corporation
New England Biolabs
Fortis Life Sciences
Quantabio
BIO-HELIX
MP Biomedicals
Avantor, Inc.
Intact Genomics, Inc.
Solis BioDyne
Applied Biological Materials Inc.
Merck KGAA
TIANGEN Biotech(Beijing)Co., Ltd
EnzyQuest
Canvax
Zymo Research Corporation
NZYtech
Abbexa
Boca Scientific Inc.
GeneDireX, Inc.